US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relmada Therapeutics, Inc.

0.3452

+0.02287.07%

Volume:1.92M

Turnover:678.17K

Market Cap:11.46M

PE:-0.13

High:0.3750

Open:0.3200

Low:0.3200

Close:0.3224

Loading ...

Overview Company News Filings

Calendar of U.S. Earnings Expected in the Week Ahead

Relmada Therapeutics Inc expected to post a loss of 70 cents a share - Earnings Preview

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

Asarina Pharma Ab (Publ) - Signs Asset Purchase Agreement With Relmada Therapeutics

THOMSON REUTERS

Relmada Therapeutics acquires Sepranolone from Asarina Pharma

Relmada Therapeutics Inc - Acquires Sepranolone for EUR 3 Million

THOMSON REUTERS

Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome From Asarina Pharma Ab

THOMSON REUTERS

BRIEF-Relmada Therapeutics Acquires Potential Therapy For Tourette Syndrome From Asarina Pharma AB

Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome From Asarina Pharma Ab

THOMSON REUTERS

Relmada Therapeutics: Purchases Sepranolone, for Treatment of Tourette Syndrome and Other Compulsion-Related Conditions From Asarina Pharma Ab

THOMSON REUTERS

BUZZ-Relmada Therapeutics explores strategic options; shares up

Relmada Therapeutics Shares up 7% After Co Says It Will Explore Strategic Alternatives Including a Sale

THOMSON REUTERS

Relmada Therapeutics Exploring Sale After Lead Program Failure

Relmada discontinues late-stage trials for depression drug, explores sale

BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017

Relmada Therapeutics to Discontinue the Reliance Ii and Relight Phase 3 Studies of Rel-1017

THOMSON REUTERS

Relmada Therapeutics Inc: Will Continue to Advance Phase 1 Study of Rel-P11, an Investigational Agent for Treatment of Metabolic Disease

THOMSON REUTERS

Relmada Therapeutics Inc: to Explore Strategic Alternatives

THOMSON REUTERS

Press Release: Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017

Relmada Shares Continue Downward Spiral After Downgrades

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RLMD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":0.3452,"timestamp":1746126265288,"preClose":0.3224,"halted":0,"volume":1924860,"delay":0,"floatShares":30568066,"shares":33191622,"eps":-2.651505,"marketStatus":"Trading","change":0.0228,"latestTime":"05-01 15:05:04 EDT","open":0.32,"high":0.375,"low":0.32,"amount":678170.8328976,"amplitude":0.170596,"askPrice":0.3453,"askSize":100,"bidPrice":0.342,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-2.651505,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3224,"preHourTrading":{"tag":"盘前","latestPrice":0.33,"preClose":0.3224,"latestTime":"09:28 EDT","volume":28915,"amount":9479.707571,"timestamp":1746106112417},"postHourTrading":{"tag":"盘后","latestPrice":0.328524,"preClose":0.3224,"latestTime":"19:55 EDT","volume":22720,"amount":7265.7468,"timestamp":1746057329888},"volumeRatio":0.368171,"impliedVol":1.0702,"impliedVolPercentile":0.068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLMD\",,,,,undefined,":{"symbol":"RLMD","floatShares":30568066,"roa":"-73.14%","roe":"-132.33%","lyrEps":-2.651505,"volumeRatio":0.368171,"shares":33191622,"dividePrice":0,"high":0.375,"amplitude":0.170596,"preClose":0.3224,"low":0.32,"week52Low":0.2404,"pbRate":"0.32","week52High":4.47,"institutionHeld":0,"latestPrice":0.3452,"committee":0.5,"eps":-2.651505,"divideRate":0,"volume":1924860,"delay":0,"ttmEps":-2.651505,"open":0.32,"prevYearClose":0.52,"prevWeekClose":0.6451,"prevMonthClose":0.3224,"prevQuarterClose":0.27,"fiveDayClose":0.7373,"twentyDayClose":0.3031,"sixtyDayClose":0.3401},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RLMD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TH","ACRV","TITN","CURV","OUST","LPTX","WOR","CBUS","BLRX","JKS","RLMD","ASO","THRD","NKE","DERM","BCAB","BRNS","FLUX","SOWG","COYA","DRI","PL","MBRX","CELC","GDEV","MREO","LVTX","JEF","ALUR","BBNX","IFRX","SPRY","CMC","MNSO","TELA","CDLR","SKYE","NKTX","BRAG","LEN","FBRX","MLKN","MGNX","PAYX","SLS","RUM","KLC","SBS"],"gpt_icon":1},{"id":"2519330968","title":"Relmada Therapeutics Inc  expected to post a loss of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519330968","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519330968?lang=en_us&edition=fundamental","pubTime":"2025-03-15 04:56","pubTimestamp":1741985765,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics Inc  expected to post a loss of70cents a share - Earnings Preview Relmada Therapeutics Inc RLMD.OQ RLMD.O is expected to show no change in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX26S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD"],"gpt_icon":0},{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNTM","PSYGF","BK4547","BK4168","NUMIF","BK4139","KTTA","SPRC","AGNPF","FLHLF","SEEL","DRUG","IXHL","BK4007","ENVB","SNPX","RVVTF","GHRS","SILO","PHRRF","MDXXF","ATAI","ENTBF","NRXP","ALID","CMPS","OPTHF","BK4202","RLMD","CYBN","PBM","MYCOF","MIRA","CMND","MNMD","BK4539","BETRF"],"gpt_icon":0},{"id":"2509760718","title":"Asarina Pharma Ab (Publ) - Signs Asset Purchase Agreement With Relmada Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2509760718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509760718?lang=en_us&edition=fundamental","pubTime":"2025-02-07 15:30","pubTimestamp":1738913420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nFWN3OY0K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2509278640","title":"Relmada Therapeutics acquires Sepranolone from Asarina Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278640","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509278640?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:45","pubTimestamp":1738845925,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics (RLMD) announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma AB, being developed for th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-acquires-sepranolone-from-asarina-pharma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/relmada-therapeutics-acquires-sepranolone-from-asarina-pharma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RLMD","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2509220388","title":"Relmada Therapeutics Inc - Acquires Sepranolone for EUR 3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220388","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509220388?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:30","pubTimestamp":1738845001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA6FC2FD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2509220362","title":"Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome From Asarina Pharma Ab","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220362","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509220362?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:30","pubTimestamp":1738845001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA6FC2FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2509224284","title":"BRIEF-Relmada Therapeutics Acquires Potential Therapy For Tourette Syndrome From Asarina Pharma AB","url":"https://stock-news.laohu8.com/highlight/detail?id=2509224284","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509224284?lang=en_us&edition=fundamental","pubTime":"2025-02-06 19:55","pubTimestamp":1738842925,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics Acquires Potential Therapy For Tourette Syndrome From Asarina Pharma ABFeb 6  - Relmada Therapeutics Inc RLMD.O:RELMADA THERAPEUTICS ACQUIRES POTENTIAL THERAPY FOR TOURETTE SYNDROME FROM ASARINA PHARMA ABRELMADA THERAPEUTICS: PURCHASES SEPRANOLONE, FOR  TREATMENT OF TOURETTE SYNDROME AND OTHER COMPULSION-RELATED CONDITIONS FROM ASARINA PHARMA ABSource text: [ID:n0001213900-25-010711]Further company coverage: RLMD.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2509221437","title":"Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome From Asarina Pharma Ab","url":"https://stock-news.laohu8.com/highlight/detail?id=2509221437","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509221437?lang=en_us&edition=fundamental","pubTime":"2025-02-06 19:41","pubTimestamp":1738842069,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2509221060","title":"Relmada Therapeutics: Purchases Sepranolone, for  Treatment of Tourette Syndrome and Other Compulsion-Related Conditions From Asarina Pharma Ab","url":"https://stock-news.laohu8.com/highlight/detail?id=2509221060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509221060?lang=en_us&edition=fundamental","pubTime":"2025-02-06 19:41","pubTimestamp":1738842069,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nFWN3OX0AZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2490677442","title":"BUZZ-Relmada Therapeutics explores strategic options; shares up","url":"https://stock-news.laohu8.com/highlight/detail?id=2490677442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490677442?lang=en_us&edition=fundamental","pubTime":"2024-12-09 23:58","pubTimestamp":1733759912,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Relmada Therapeutics    rise 4.9% to 48 cents     ** Co says it has commenced a process to explore strategic alternatives after discontinuing two late-stage studies planned for the development of its depression drug   ** Co plans to consider a wide range of options including sale of company assets, a sale of the company, a merger or a reverse merger; adds it has not set a timetable for completion of the evaluation process   ** Says co is in the process of engaging a financial advisor to assist in the strategic review process   ** The stock fell more than 70% last week after the company said its depression drug, esmethadone, was \"unlikely\" to meet the main goal of a late-stage trial    ** Including session moves, stock down 88.4% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4139","RLMD"],"gpt_icon":0},{"id":"2490334773","title":"Relmada Therapeutics Shares up 7% After Co Says It Will Explore Strategic Alternatives Including a Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2490334773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490334773?lang=en_us&edition=fundamental","pubTime":"2024-12-09 22:34","pubTimestamp":1733754857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490772453","title":"Relmada Therapeutics Exploring Sale After Lead Program Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2490772453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490772453?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:59","pubTimestamp":1733749140,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics has put itself up for sale following the failure of the biotechnology company's lead asset in a late-stage study.Relmada on Monday said it is ending Phase 3 studies of its REL-1017 program and exploring ways to maximize shareholder value on the heels of last week's news that one of the studies was unlikely to meet its primary endpoint in major depressive disorder.Relmada said it is working to hire a financial adviser to assist in a strategic review process that will include a range of options, including a potential sale of the Coral Gables, Fla., company or its assets.The company said it will also continue to advance a Phase 1 study of its REL-P11 investigational agent for the treatment of metabolic disease.Relmada shares collapsed last week after the company disclosed the study failure, ending Friday's session at 45.8 cents, down about 85% for the week.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RLMD","BK4139","BK4007"],"gpt_icon":0},{"id":"2490729001","title":"Relmada discontinues late-stage trials for depression drug, explores sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729001","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729001?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:39","pubTimestamp":1733747979,"startTime":"0","endTime":"0","summary":"Dec 9  - Relmada Therapeutics    said on Monday it would discontinue the two late-stage studies planned for the development of its depression drug and explore strategic alternatives including a sale.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490294627","title":"BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490294627","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490294627?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:35","pubTimestamp":1733747754,"startTime":"0","endTime":"0","summary":"BRIEF-Relmada Therapeutics To Discontinue The Reliance Ii And Relight Phase 3 Studies Of Rel-1017Dec 9 (Reuters) - Relmada Therapeutics RLMD.O:RELMADA THERAPEUTICS TO DISCONTINUE THE RELIANCE II AND R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729658","title":"Relmada Therapeutics to Discontinue the Reliance Ii and Relight Phase 3 Studies of Rel-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729658?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729648","title":"Relmada Therapeutics Inc: Will Continue to Advance Phase 1 Study of Rel-P11, an Investigational Agent for Treatment of Metabolic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729648?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2490729645","title":"Relmada Therapeutics Inc: to Explore Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729645","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729645?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1BH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RLMD"],"gpt_icon":0},{"id":"2490729546","title":"Press Release: Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017","url":"https://stock-news.laohu8.com/highlight/detail?id=2490729546","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490729546?lang=en_us&edition=fundamental","pubTime":"2024-12-09 20:30","pubTimestamp":1733747400,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics has Commenced a Process to Explore Strategic Alternatives to Maximize Shareholder Value. CORAL GABLES, Fla., Dec. 09, 2024  -- Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that in light of the recent data monitoring committee  evaluation of the full dataset from the Reliance II Phase 3 study of the Company's REL-1017 program, the Company will discontinue the Reliance II and Relight Phase 3 studies. The Company will continue to advance the Phase 1 study of REL-P11, an investigational agent for the treatment of metabolic disease, currently in a Phase 1 first-in-human study.The Company has not set a timetable for completion of the evaluation process and does not intend to disclose further developments or guidance on the status of its exploration of strategic alternatives unless and until it is determined that further disclosure is appropriate or necessary.Relmada Therapeutics is a l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","RLMD","BK4007","BK4588","BK4099","03160","BK4555","TM","LENZ","CNS","BK4135"],"gpt_icon":0},{"id":"2489965454","title":"Relmada Shares Continue Downward Spiral After Downgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2489965454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489965454?lang=en_us&edition=fundamental","pubTime":"2024-12-06 02:31","pubTimestamp":1733423517,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  shares continued falling on Thursday after some analysts downgraded its stock following failure in late-stage trial of anti-depressant candidate.Mizuho downgraded the stock to neutral from outperform and slashed its price target to $1 from $23, while Leerink Partners lowered its rating to market perform from outperform, also with a $1 price target.Relmada on Wednesday said that an independent data monitoring committee has determined that a late-stage study of REL-1017 as an adjunctive treatment for major depressive disorder is \"futile.\" The company will determine its next steps after assessing the full dataset.The company's stock was down nearly 16% in recent trading after falling more than 70% on Wednesday.Price: 0.53, Change: -0.10, Percent Change: -15.71","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLMD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-27","symbol":"RLMD","fiscalQuarterEnding":"2024/12","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2024-11-07","symbol":"RLMD","fiscalQuarterEnding":"2024/09","expectedEps":-0.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-08-07","symbol":"RLMD","fiscalQuarterEnding":"2024/06","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-05-08","symbol":"RLMD","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.72},{"market":"US","date":"2024-03-19","symbol":"RLMD","fiscalQuarterEnding":"2023/12","expectedEps":-0.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"post","actualEps":-0.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RLMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RLMD","date":"2025-04-30","current":-0.117902,"percent":0.965686,"low":-42.205269,"twenty":-10.063067,"median":-2.859389,"eighty":-0.677139,"high":-0.088966,"avg":-6.039257,"sd":8.079603,"marketCap":9429739},"quantilePoints":[{"date":"2020-05-01","current":-39.228299,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":588628435},{"date":"2020-05-08","current":-41.169801,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":617761060},{"date":"2020-05-15","current":-30.075697,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":691513959},{"date":"2020-05-22","current":-30.796192,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":708079898},{"date":"2020-05-29","current":-31.867019,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":732700834},{"date":"2020-06-05","current":-31.503466,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":724341874},{"date":"2020-06-12","current":-31.047373,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":713855179},{"date":"2020-06-19","current":-31.569567,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":725861685},{"date":"2020-06-26","current":-28.667758,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":659141987},{"date":"2020-07-02","current":-28.277765,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":650175103},{"date":"2020-07-10","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-17","current":-27.980313,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":643335953},{"date":"2020-07-24","current":-25.785779,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":592878232},{"date":"2020-07-31","current":-24.040727,"twenty":-5.548525,"median":-1.733041,"eighty":-0.357515,"marketCap":552755224},{"date":"2020-08-07","current":-23.743276,"twenty":-5.700374,"median":-1.733041,"eighty":-0.357515,"marketCap":545916075},{"date":"2020-08-14","current":-19.888133,"twenty":-5.712286,"median":-1.733041,"eighty":-0.357515,"marketCap":596411270},{"date":"2020-08-21","current":-20.876662,"twenty":-5.737576,"median":-1.733041,"eighty":-0.357515,"marketCap":626055570},{"date":"2020-08-28","current":-18.637777,"twenty":-5.855718,"median":-1.733041,"eighty":-0.357515,"marketCap":558915236},{"date":"2020-09-04","current":-19.610276,"twenty":-5.948456,"median":-1.733041,"eighty":-0.357515,"marketCap":588078818},{"date":"2020-09-11","current":-19.36448,"twenty":-6.126741,"median":-1.733041,"eighty":-0.357515,"marketCap":580707803},{"date":"2020-09-18","current":-21.469779,"twenty":-6.279615,"median":-1.733041,"eighty":-0.357515,"marketCap":643842150},{"date":"2020-09-25","current":-19.66371,"twenty":-6.401962,"median":-1.733041,"eighty":-0.357515,"marketCap":589681212},{"date":"2020-10-02","current":-20.956813,"twenty":-6.49254,"median":-1.758166,"eighty":-0.357515,"marketCap":628459162},{"date":"2020-10-09","current":-20.860631,"twenty":-6.752577,"median":-1.818793,"eighty":-0.357515,"marketCap":625574851},{"date":"2020-10-16","current":-18.62709,"twenty":-13.145747,"median":-1.818793,"eighty":-0.357515,"marketCap":558594757},{"date":"2020-10-23","current":-17.814894,"twenty":-14.590145,"median":-1.853436,"eighty":-0.357515,"marketCap":534238359},{"date":"2020-10-30","current":-16.527134,"twenty":-14.890092,"median":-1.884167,"eighty":-0.357515,"marketCap":495620649},{"date":"2020-11-06","current":-17.040101,"twenty":-15.202709,"median":-1.905402,"eighty":-0.357515,"marketCap":511003637},{"date":"2020-11-13","current":-12.23902,"twenty":-15.348585,"median":-1.975556,"eighty":-0.357515,"marketCap":528986501},{"date":"2020-11-20","current":-13.854856,"twenty":-15.348585,"median":-2.000672,"eighty":-0.357515,"marketCap":598825063},{"date":"2020-11-27","current":-13.524173,"twenty":-15.348585,"median":-2.052637,"eighty":-0.357515,"marketCap":584532520},{"date":"2020-12-04","current":-13.152155,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":568453410},{"date":"2020-12-11","current":-12.344237,"twenty":-15.348585,"median":-2.07862,"eighty":-0.357515,"marketCap":533534129},{"date":"2020-12-18","current":-12.663647,"twenty":-15.348585,"median":-2.160184,"eighty":-0.357515,"marketCap":547339426},{"date":"2020-12-24","current":-12.069921,"twenty":-15.348585,"median":-2.191878,"eighty":-0.357515,"marketCap":521677815},{"date":"2020-12-31","current":-12.051132,"twenty":-15.348585,"median":-2.251839,"eighty":-0.357515,"marketCap":520865738},{"date":"2021-01-08","current":-13.309981,"twenty":-15.348585,"median":-2.315052,"eighty":-0.357515,"marketCap":575274850},{"date":"2021-01-15","current":-13.854856,"twenty":-15.348585,"median":-2.359402,"eighty":-0.357515,"marketCap":598825063},{"date":"2021-01-22","current":-13.426472,"twenty":-15.348585,"median":-2.390413,"eighty":-0.361852,"marketCap":580309723},{"date":"2021-01-29","current":-12.280355,"twenty":-15.348585,"median":-2.511008,"eighty":-0.36481,"marketCap":530773069},{"date":"2021-02-05","current":-12.716255,"twenty":-15.348585,"median":-2.576427,"eighty":-0.370059,"marketCap":549613239},{"date":"2021-02-12","current":-13.704546,"twenty":-15.348585,"median":-2.617786,"eighty":-0.372159,"marketCap":592328453},{"date":"2021-02-19","current":-14.035229,"twenty":-15.348585,"median":-2.645672,"eighty":-0.372159,"marketCap":606620996},{"date":"2021-02-26","current":-12.528367,"twenty":-15.348585,"median":-2.728189,"eighty":-0.372159,"marketCap":541492476},{"date":"2021-03-05","current":-12.862808,"twenty":-15.354462,"median":-2.841532,"eighty":-0.371634,"marketCap":555947434},{"date":"2021-03-12","current":-13.779701,"twenty":-15.354462,"median":-2.841532,"eighty":-0.391734,"marketCap":595576758},{"date":"2021-03-19","current":-13.742123,"twenty":-15.354462,"median":-2.877762,"eighty":-0.424703,"marketCap":593952605},{"date":"2021-03-26","current":-9.271938,"twenty":-15.348585,"median":-2.890274,"eighty":-0.43007,"marketCap":551276015},{"date":"2021-04-01","current":-10.323333,"twenty":-15.348585,"median":-2.926862,"eighty":-0.438333,"marketCap":613788141},{"date":"2021-04-09","current":-9.923356,"twenty":-15.354462,"median":-2.987177,"eighty":-0.437014,"marketCap":590006991},{"date":"2021-04-16","current":-9.771253,"twenty":-15.354462,"median":-3.013299,"eighty":-0.437014,"marketCap":580963455},{"date":"2021-04-23","current":-10.376851,"twenty":-15.354462,"median":-3.039204,"eighty":-0.437014,"marketCap":616970126},{"date":"2021-04-30","current":-10.861329,"twenty":-15.354462,"median":-3.077954,"eighty":-0.437014,"marketCap":645775463},{"date":"2021-05-07","current":-10.236014,"twenty":-15.354462,"median":-3.096464,"eighty":-0.437014,"marketCap":608596482},{"date":"2021-05-14","current":-8.003248,"twenty":-15.354462,"median":-3.13772,"eighty":-0.437014,"marketCap":568216697},{"date":"2021-05-21","current":-8.968464,"twenty":-15.354462,"median":-3.169112,"eighty":-0.437014,"marketCap":636745344},{"date":"2021-05-28","current":-8.183043,"twenty":-15.354462,"median":-3.187536,"eighty":-0.437014,"marketCap":580981837},{"date":"2021-06-04","current":-7.12793,"twenty":-15.354462,"median":-3.192703,"eighty":-0.437014,"marketCap":506070620},{"date":"2021-06-11","current":-7.366868,"twenty":-15.354462,"median":-3.196717,"eighty":-0.437014,"marketCap":523034820},{"date":"2021-06-18","current":-7.310091,"twenty":-15.354462,"median":-3.215186,"eighty":-0.437014,"marketCap":519003723},{"date":"2021-06-25","current":-8.126266,"twenty":-15.354462,"median":-3.245915,"eighty":-0.437014,"marketCap":576950740},{"date":"2021-07-02","current":-7.71463,"twenty":-15.354462,"median":-3.278609,"eighty":-0.437014,"marketCap":547725288},{"date":"2021-07-09","current":-8.097877,"twenty":-15.354462,"median":-3.296823,"eighty":-0.437014,"marketCap":574935192},{"date":"2021-07-16","current":-7.373965,"twenty":-15.354462,"median":-3.315038,"eighty":-0.443169,"marketCap":523538707},{"date":"2021-07-23","current":-6.127228,"twenty":-15.354462,"median":-3.370574,"eighty":-0.443169,"marketCap":435022538},{"date":"2021-07-30","current":-6.150886,"twenty":-15.354462,"median":-3.371104,"eighty":-0.555367,"marketCap":436702162},{"date":"2021-08-06","current":-5.568917,"twenty":-15.354462,"median":-3.380611,"eighty":-0.578507,"marketCap":395383418},{"date":"2021-08-13","current":-4.61934,"twenty":-15.354462,"median":-3.397035,"eighty":-0.605119,"marketCap":399257730},{"date":"2021-08-20","current":-4.534433,"twenty":-15.354462,"median":-3.424324,"eighty":-0.659499,"marketCap":391919075},{"date":"2021-08-27","current":-4.890234,"twenty":-15.354462,"median":-3.448899,"eighty":-0.746275,"marketCap":422671531},{"date":"2021-09-03","current":-4.932687,"twenty":-15.354462,"median":-3.460753,"eighty":-0.821481,"marketCap":426340858},{"date":"2021-09-10","current":-5.260185,"twenty":-15.354462,"median":-3.485622,"eighty":-0.850406,"marketCap":454647095},{"date":"2021-09-17","current":-5.571511,"twenty":-15.354462,"median":-3.500762,"eighty":-0.850406,"marketCap":481555494},{"date":"2021-09-24","current":-5.882836,"twenty":-15.354462,"median":-3.51567,"eighty":-0.850406,"marketCap":508463892},{"date":"2021-10-01","current":-5.40574,"twenty":-15.354462,"median":-3.578556,"eighty":-0.970791,"marketCap":467227645},{"date":"2021-10-08","current":-5.290509,"twenty":-15.354462,"median":-3.584692,"eighty":-1.000536,"marketCap":457268043},{"date":"2021-10-15","current":-4.777025,"twenty":-15.354462,"median":-3.605816,"eighty":-1.014057,"marketCap":412886659},{"date":"2021-10-22","current":-4.815435,"twenty":-15.354462,"median":-3.628468,"eighty":-1.022224,"marketCap":416206526},{"date":"2021-10-29","current":-4.744679,"twenty":-15.354462,"median":-3.668784,"eighty":-1.054619,"marketCap":410090981},{"date":"2021-11-05","current":-5.314768,"twenty":-15.354462,"median":-3.690124,"eighty":-1.081661,"marketCap":459364801},{"date":"2021-11-12","current":-3.567592,"twenty":-15.354462,"median":-3.789733,"eighty":-1.415629,"marketCap":400053540},{"date":"2021-11-19","current":-3.187695,"twenty":-15.354462,"median":-3.789733,"eighty":-1.448079,"marketCap":357453623},{"date":"2021-11-26","current":-2.943811,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458021,"marketCap":330105528},{"date":"2021-12-03","current":-2.646772,"twenty":-15.354462,"median":-3.789733,"eighty":-1.458229,"marketCap":296796951},{"date":"2021-12-10","current":-4.42415,"twenty":-15.354462,"median":-3.795557,"eighty":-1.477343,"marketCap":496104008},{"date":"2021-12-17","current":-4.705268,"twenty":-15.354462,"median":-3.795557,"eighty":-1.499231,"marketCap":527627378},{"date":"2021-12-23","current":-5.501431,"twenty":-15.354462,"median":-3.909674,"eighty":-1.532958,"marketCap":616905369},{"date":"2021-12-31","current":-5.570662,"twenty":-15.354462,"median":-4.004888,"eighty":-1.552453,"marketCap":624668672},{"date":"2022-01-07","current":-5.170108,"twenty":-15.348585,"median":-4.217285,"eighty":-1.558965,"marketCap":579752416},{"date":"2022-01-14","current":-4.91049,"twenty":-15.348585,"median":-4.421677,"eighty":-1.560442,"marketCap":550640028},{"date":"2022-01-21","current":-4.591531,"twenty":-15.348585,"median":-4.551617,"eighty":-1.56326,"marketCap":514873379},{"date":"2022-01-28","current":-4.32944,"twenty":-15.348585,"median":-4.580166,"eighty":-1.579649,"marketCap":485483730},{"date":"2022-02-04","current":-4.195923,"twenty":-15.348585,"median":-4.580166,"eighty":-1.584662,"marketCap":470511645},{"date":"2022-02-11","current":-4.569278,"twenty":-15.348585,"median":-4.605436,"eighty":-1.606919,"marketCap":512378032},{"date":"2022-02-18","current":-4.517354,"twenty":-15.348585,"median":-4.634752,"eighty":-1.627238,"marketCap":506555554},{"date":"2022-02-25","current":-5.081097,"twenty":-15.348585,"median":-4.649032,"eighty":-1.637901,"marketCap":569771026},{"date":"2022-03-04","current":-5.093459,"twenty":-15.348585,"median":-4.686724,"eighty":-1.645574,"marketCap":571157330},{"date":"2022-03-11","current":-5.498958,"twenty":-15.348585,"median":-4.748722,"eighty":-1.671902,"marketCap":616628108},{"date":"2022-03-18","current":-5.953908,"twenty":-15.348585,"median":-4.779046,"eighty":-1.671902,"marketCap":667644102},{"date":"2022-03-25","current":-6.013944,"twenty":-15.348585,"median":-4.795535,"eighty":-1.724543,"marketCap":756264367},{"date":"2022-04-01","current":-6.866406,"twenty":-15.348585,"median":-4.819018,"eighty":-1.749505,"marketCap":863463006},{"date":"2022-04-08","current":-6.209434,"twenty":-15.348585,"median":-4.84677,"eighty":-1.815329,"marketCap":780847514},{"date":"2022-04-14","current":-6.092407,"twenty":-15.348585,"median":-4.910514,"eighty":-1.818793,"marketCap":766131202},{"date":"2022-04-22","current":-5.727284,"twenty":-15.348585,"median":-4.93957,"eighty":-1.836115,"marketCap":720216309},{"date":"2022-04-29","current":-5.877078,"twenty":-15.348585,"median":-4.99703,"eighty":-1.869901,"marketCap":739053188},{"date":"2022-05-06","current":-4.443703,"twenty":-15.348585,"median":-5.010782,"eighty":-1.905402,"marketCap":636704471},{"date":"2022-05-13","current":-4.144386,"twenty":-15.348585,"median":-5.010782,"eighty":-1.940046,"marketCap":593817642},{"date":"2022-05-20","current":-4.20718,"twenty":-15.348585,"median":-5.010782,"eighty":-1.992011,"marketCap":602814879},{"date":"2022-05-27","current":-4.148572,"twenty":-15.348585,"median":-5.010782,"eighty":-2.040855,"marketCap":594417457},{"date":"2022-06-03","current":-4.058568,"twenty":-15.348585,"median":-5.010782,"eighty":-2.078009,"marketCap":581521418},{"date":"2022-06-10","current":-3.767624,"twenty":-15.348585,"median":-5.010782,"eighty":-2.07862,"marketCap":539834220},{"date":"2022-06-17","current":-3.830418,"twenty":-15.348585,"median":-5.010782,"eighty":-2.107186,"marketCap":548831457},{"date":"2022-06-24","current":-4.112989,"twenty":-15.354462,"median":-5.011529,"eighty":-2.165229,"marketCap":589319023},{"date":"2022-07-01","current":-3.830418,"twenty":-15.354462,"median":-5.011529,"eighty":-2.251839,"marketCap":548831457},{"date":"2022-07-08","current":-3.958098,"twenty":-15.354462,"median":-5.011529,"eighty":-2.306182,"marketCap":567125838},{"date":"2022-07-15","current":-4.70325,"twenty":-15.354462,"median":-5.011529,"eighty":-2.355854,"marketCap":673893051},{"date":"2022-07-22","current":-4.962798,"twenty":-15.354462,"median":-5.02511,"eighty":-2.393877,"marketCap":711081630},{"date":"2022-07-29","current":-5.358398,"twenty":-15.354462,"median":-5.051511,"eighty":-2.514569,"marketCap":767764224},{"date":"2022-08-05","current":-5.479799,"twenty":-15.354462,"median":-5.071206,"eighty":-2.577332,"marketCap":785158882},{"date":"2022-08-12","current":-5.583625,"twenty":-15.354462,"median":-5.085412,"eighty":-2.618223,"marketCap":874761073},{"date":"2022-08-19","current":-5.566356,"twenty":-15.354462,"median":-5.130803,"eighty":-2.648853,"marketCap":872055627},{"date":"2022-08-26","current":-5.658457,"twenty":-15.354462,"median":-5.14291,"eighty":-2.717642,"marketCap":886484675},{"date":"2022-09-02","current":-5.702589,"twenty":-15.354462,"median":-5.161645,"eighty":-2.789962,"marketCap":893398594},{"date":"2022-09-09","current":-6.118962,"twenty":-15.354462,"median":-5.168988,"eighty":-2.83992,"marketCap":958629919},{"date":"2022-09-16","current":-6.537255,"twenty":-15.354462,"median":-5.170108,"eighty":-2.841532,"marketCap":1024161848},{"date":"2022-09-23","current":-6.120881,"twenty":-15.354462,"median":-5.21571,"eighty":-2.8635,"marketCap":958930524},{"date":"2022-09-30","current":-7.103292,"twenty":-15.354462,"median":-5.232811,"eighty":-2.877762,"marketCap":1112840376},{"date":"2022-10-07","current":-6.569874,"twenty":-15.354462,"median":-5.260185,"eighty":-2.877762,"marketCap":1029272136},{"date":"2022-10-14","current":-1.189638,"twenty":-15.354462,"median":-5.278901,"eighty":-2.870556,"marketCap":186375211},{"date":"2022-10-21","current":-1.345059,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":210724231},{"date":"2022-10-28","current":-1.256795,"twenty":-15.354462,"median":-5.278901,"eighty":-2.841532,"marketCap":196896392},{"date":"2022-11-04","current":-1.220339,"twenty":-15.354462,"median":-5.278901,"eighty":-2.789962,"marketCap":191184894},{"date":"2022-11-11","current":-1.245325,"twenty":-15.354462,"median":-5.278901,"eighty":-2.717642,"marketCap":191129939},{"date":"2022-11-18","current":-1.164918,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":178789265},{"date":"2022-11-25","current":-1.029599,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":158020815},{"date":"2022-12-02","current":-0.902125,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":138456333},{"date":"2022-12-09","current":-0.525586,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":80665864},{"date":"2022-12-16","current":-0.660905,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":101434314},{"date":"2022-12-23","current":-0.590304,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":90598601},{"date":"2022-12-30","current":-0.684438,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":105046218},{"date":"2023-01-06","current":-0.645216,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99026377},{"date":"2023-01-13","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-01-20","current":-0.933504,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":143272206},{"date":"2023-01-27","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-03","current":-0.80799,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":124008716},{"date":"2023-02-10","current":-0.733467,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":112571019},{"date":"2023-02-17","current":-0.719739,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":110464075},{"date":"2023-02-24","current":-0.651099,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":99929353},{"date":"2023-03-03","current":-0.698166,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":107153162},{"date":"2023-03-10","current":-0.56677,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":86986696},{"date":"2023-03-17","current":-0.484402,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":74345031},{"date":"2023-03-24","current":-0.435071,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":68325190},{"date":"2023-03-31","current":-0.433154,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":68024198},{"date":"2023-04-06","current":-0.425488,"twenty":-15.348585,"median":-5.270935,"eighty":-2.684884,"marketCap":66820230},{"date":"2023-04-14","current":-0.490653,"twenty":-15.354462,"median":-5.278901,"eighty":-2.704227,"marketCap":77053959},{"date":"2023-04-21","current":-0.511735,"twenty":-15.354462,"median":-5.278901,"eighty":-2.644504,"marketCap":80364872},{"date":"2023-04-28","current":-0.525152,"twenty":-15.354462,"median":-5.278901,"eighty":-2.598617,"marketCap":82471816},{"date":"2023-05-05","current":-0.58265,"twenty":-15.354462,"median":-5.278901,"eighty":-2.528919,"marketCap":91501577},{"date":"2023-05-12","current":-0.664355,"twenty":-15.354462,"median":-5.278901,"eighty":-2.410667,"marketCap":95414473},{"date":"2023-05-19","current":-0.651781,"twenty":-15.354462,"median":-5.278901,"eighty":-2.359402,"marketCap":93608521},{"date":"2023-05-26","current":-0.595195,"twenty":-15.354462,"median":-5.278901,"eighty":-2.316826,"marketCap":85481736},{"date":"2023-06-02","current":-0.570046,"twenty":-15.354462,"median":-5.278901,"eighty":-2.284445,"marketCap":81869832},{"date":"2023-06-09","current":-0.588908,"twenty":-15.354462,"median":-5.278901,"eighty":-2.165229,"marketCap":84578760},{"date":"2023-06-16","current":-0.534418,"twenty":-15.354462,"median":-5.278901,"eighty":-2.143555,"marketCap":76752967},{"date":"2023-06-23","current":-0.536514,"twenty":-15.360338,"median":-5.282659,"eighty":-2.165229,"marketCap":77053959},{"date":"2023-06-30","current":-0.521844,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":74947015},{"date":"2023-07-07","current":-0.52394,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":75248007},{"date":"2023-07-14","current":-0.591004,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":84879752},{"date":"2023-07-21","current":-0.62244,"twenty":-15.366215,"median":-5.286416,"eighty":-2.165229,"marketCap":89394632},{"date":"2023-07-28","current":-0.519748,"twenty":-15.366215,"median":-5.286416,"eighty":-2.085105,"marketCap":74646023},{"date":"2023-08-04","current":-0.546993,"twenty":-15.366215,"median":-5.286416,"eighty":-2.022579,"marketCap":78558919},{"date":"2023-08-11","current":-0.66738,"twenty":-15.366215,"median":-5.286416,"eighty":-1.995475,"marketCap":86083720},{"date":"2023-08-18","current":-0.665046,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":85782728},{"date":"2023-08-25","current":-0.744385,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":96016457},{"date":"2023-09-01","current":-0.788722,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":101735306},{"date":"2023-09-08","current":-0.828391,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":106852170},{"date":"2023-09-15","current":-0.772387,"twenty":-15.366215,"median":-5.286416,"eighty":-1.972611,"marketCap":99628361},{"date":"2023-09-22","current":-0.669713,"twenty":-15.366215,"median":-5.286416,"eighty":-1.912331,"marketCap":86384712},{"date":"2023-09-29","current":-0.686048,"twenty":-15.445182,"median":-5.286416,"eighty":-1.627406,"marketCap":88491656},{"date":"2023-10-06","current":-0.700049,"twenty":-15.518272,"median":-5.28644,"eighty":-1.900782,"marketCap":90297609},{"date":"2023-10-13","current":-0.746719,"twenty":-15.518272,"median":-5.28644,"eighty":-1.878374,"marketCap":96317449},{"date":"2023-10-20","current":-0.723384,"twenty":-15.518272,"median":-5.28644,"eighty":-1.444835,"marketCap":93307529},{"date":"2023-10-27","current":-0.732718,"twenty":-15.783249,"median":-5.288487,"eighty":-1.358874,"marketCap":94511497},{"date":"2023-11-03","current":-0.711716,"twenty":-15.783249,"median":-5.288487,"eighty":-1.26447,"marketCap":91802569},{"date":"2023-11-10","current":-0.806631,"twenty":-15.783249,"median":-5.288487,"eighty":-1.225327,"marketCap":89996616},{"date":"2023-11-17","current":-0.79584,"twenty":-15.783249,"median":-5.288487,"eighty":-1.187047,"marketCap":88792648},{"date":"2023-11-24","current":-0.782351,"twenty":-15.783249,"median":-5.288487,"eighty":-1.150072,"marketCap":87287688},{"date":"2023-11-30","current":-0.677139,"twenty":-15.828956,"median":-5.290509,"eighty":-1.129618,"marketCap":75548999},{"date":"2023-12-08","current":-0.690627,"twenty":-15.874664,"median":-5.294552,"eighty":-1.029599,"marketCap":77053959},{"date":"2023-12-15","current":-0.674441,"twenty":-15.920371,"median":-5.298596,"eighty":-0.904086,"marketCap":75248007},{"date":"2023-12-22","current":-0.79584,"twenty":-15.920371,"median":-5.298596,"eighty":-0.874579,"marketCap":88792648},{"date":"2023-12-29","current":-1.022452,"twenty":-15.966078,"median":-5.300095,"eighty":-0.866825,"marketCap":114075979},{"date":"2024-01-05","current":-0.834958,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":93157033},{"date":"2024-01-12","current":-0.89296,"twenty":-16.008223,"median":-5.301594,"eighty":-0.865648,"marketCap":99628361},{"date":"2024-01-19","current":-0.919937,"twenty":-16.050367,"median":-5.303846,"eighty":-0.860157,"marketCap":102638282},{"date":"2024-01-26","current":-0.97659,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":108959114},{"date":"2024-02-02","current":-1.23018,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":137252365},{"date":"2024-02-09","current":-1.413628,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":157719823},{"date":"2024-02-16","current":-1.421721,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":158622799},{"date":"2024-02-23","current":-1.494561,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":166749584},{"date":"2024-03-01","current":-1.65238,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":184357618},{"date":"2024-03-08","current":-1.718475,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":191731923},{"date":"2024-03-15","current":-1.356975,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":151398991},{"date":"2024-03-22","current":-1.423315,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":140611781},{"date":"2024-03-28","current":-1.401935,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":138499587},{"date":"2024-04-05","current":-1.432478,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":141517007},{"date":"2024-04-12","current":-1.423315,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":140611781},{"date":"2024-04-19","current":-1.313359,"twenty":-16.008223,"median":-5.301594,"eighty":-0.860549,"marketCap":129749068},{"date":"2024-04-26","current":-1.1301,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":111644547},{"date":"2024-05-03","current":-1.136209,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":112248031},{"date":"2024-05-10","current":-1.21595,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":114661967},{"date":"2024-05-17","current":-1.116754,"twenty":-15.966078,"median":-5.300095,"eighty":-0.860941,"marketCap":105307964},{"date":"2024-05-24","current":-0.995159,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":93841768},{"date":"2024-05-31","current":-0.97276,"twenty":-15.966078,"median":-5.288487,"eighty":-0.860941,"marketCap":91729574},{"date":"2024-06-07","current":-0.97276,"twenty":-15.966078,"median":-5.282683,"eighty":-0.860941,"marketCap":91729574},{"date":"2024-06-14","current":-0.96316,"twenty":-16.008223,"median":-5.260185,"eighty":-0.860549,"marketCap":90824348},{"date":"2024-06-21","current":-0.97276,"twenty":-16.050367,"median":-5.240733,"eighty":-0.860157,"marketCap":91729574},{"date":"2024-06-28","current":-0.95676,"twenty":-16.176801,"median":-5.256648,"eighty":-0.85898,"marketCap":90220863},{"date":"2024-07-05","current":-0.96316,"twenty":-16.176801,"median":-5.256648,"eighty":-0.85898,"marketCap":90824348},{"date":"2024-07-12","current":-1.395142,"twenty":-16.176801,"median":-5.256648,"eighty":-0.85898,"marketCap":131559520},{"date":"2024-07-15","current":-1.299146,"twenty":-16.176801,"median":-5.256648,"eighty":-0.85898,"marketCap":122507260},{"date":"2024-08-02","current":-1.180751,"twenty":-16.505977,"median":-5.288487,"eighty":-0.844814,"marketCap":111342805},{"date":"2024-08-09","current":-0.799884,"twenty":-16.505977,"median":-5.288487,"eighty":-0.843291,"marketCap":69400664},{"date":"2024-08-16","current":-0.893783,"twenty":-16.505977,"median":-5.282683,"eighty":-0.835938,"marketCap":77547699},{"date":"2024-08-23","current":-0.973771,"twenty":-16.505977,"median":-5.237401,"eighty":-0.835938,"marketCap":84487765},{"date":"2024-08-30","current":-0.918127,"twenty":-16.505977,"median":-5.20112,"eighty":-0.835938,"marketCap":79659893},{"date":"2024-09-06","current":-0.841617,"twenty":-16.505977,"median":-5.170108,"eighty":-0.835938,"marketCap":73021568},{"date":"2024-09-13","current":-1.137226,"twenty":-16.505977,"median":-5.147777,"eighty":-0.83478,"marketCap":98669640},{"date":"2024-09-20","current":-1.217214,"twenty":-16.505977,"median":-5.134847,"eighty":-0.83478,"marketCap":105609707},{"date":"2024-09-27","current":-1.140703,"twenty":-16.505977,"median":-5.095109,"eighty":-0.83478,"marketCap":98971382},{"date":"2024-10-04","current":-1.140703,"twenty":-16.505977,"median":-5.072443,"eighty":-0.83478,"marketCap":98971382},{"date":"2024-10-11","current":-1.158092,"twenty":-16.505977,"median":-5.048338,"eighty":-0.83478,"marketCap":100480092},{"date":"2024-10-18","current":-1.213736,"twenty":-16.505977,"median":-4.989452,"eighty":-0.83478,"marketCap":105307964},{"date":"2024-10-25","current":-1.262425,"twenty":-16.38143,"median":-4.952905,"eighty":-0.83478,"marketCap":109532353},{"date":"2024-10-31","current":-1.217214,"twenty":-16.38143,"median":-4.91148,"eighty":-0.83478,"marketCap":105609707},{"date":"2024-11-08","current":-1.133748,"twenty":-16.134656,"median":-4.833629,"eighty":-0.83472,"marketCap":98367898},{"date":"2024-11-15","current":-1.102479,"twenty":-16.134656,"median":-4.815435,"eighty":-0.83472,"marketCap":95350478},{"date":"2024-11-22","current":-0.959435,"twenty":-14.698849,"median":-4.78439,"eighty":-0.83472,"marketCap":82979055},{"date":"2024-11-29","current":-1.053635,"twenty":-13.999154,"median":-4.777025,"eighty":-0.83472,"marketCap":91126090},{"date":"2024-12-06","current":-0.156999,"twenty":-13.760912,"median":-4.73255,"eighty":-0.829018,"marketCap":13578390},{"date":"2024-12-13","current":-0.129088,"twenty":-13.700037,"median":-4.688598,"eighty":-0.823724,"marketCap":11164454},{"date":"2024-12-20","current":-0.123052,"twenty":-13.429478,"median":-4.649664,"eighty":-0.812813,"marketCap":10642441},{"date":"2024-12-27","current":-0.126366,"twenty":-13.355074,"median":-4.638411,"eighty":-0.80799,"marketCap":10929095},{"date":"2025-01-03","current":-0.157033,"twenty":-13.283677,"median":-4.591531,"eighty":-0.800329,"marketCap":13581408},{"date":"2025-01-10","current":-0.157696,"twenty":-13.227311,"median":-4.56186,"eighty":-0.796224,"marketCap":13638739},{"date":"2025-01-17","current":-0.132611,"twenty":-13.155913,"median":-4.528367,"eighty":-0.79584,"marketCap":11469214},{"date":"2025-01-24","current":-0.132577,"twenty":-13.152155,"median":-4.502605,"eighty":-0.789888,"marketCap":11466196},{"date":"2025-01-31","current":-0.123506,"twenty":-13.11082,"median":-4.426601,"eighty":-0.782351,"marketCap":10681667},{"date":"2025-02-07","current":-0.119319,"twenty":-13.095789,"median":-4.275044,"eighty":-0.770729,"marketCap":10319577},{"date":"2025-02-14","current":-0.114644,"twenty":-12.919174,"median":-4.16741,"eighty":-0.746719,"marketCap":9915242},{"date":"2025-02-21","current":-0.10955,"twenty":-12.716255,"median":-4.125642,"eighty":-0.737385,"marketCap":9474699},{"date":"2025-02-28","current":-0.096258,"twenty":-12.659889,"median":-4.0795,"eighty":-0.732718,"marketCap":8325062},{"date":"2025-03-07","current":-0.095211,"twenty":-12.492293,"median":-4.029264,"eighty":-0.725698,"marketCap":8234539},{"date":"2025-03-14","current":-0.094827,"twenty":-12.348747,"median":-3.987402,"eighty":-0.722917,"marketCap":8201348},{"date":"2025-03-21","current":-0.105538,"twenty":-12.242026,"median":-3.90577,"eighty":-0.711716,"marketCap":9127696},{"date":"2025-03-28","current":-0.103968,"twenty":-11.838443,"median":-3.861814,"eighty":-0.704819,"marketCap":8991912},{"date":"2025-04-04","current":-0.114499,"twenty":-10.872596,"median":-3.767624,"eighty":-0.697715,"marketCap":9157568},{"date":"2025-04-11","current":-0.118691,"twenty":-10.624723,"median":-3.541277,"eighty":-0.695792,"marketCap":9492803},{"date":"2025-04-17","current":-0.121181,"twenty":-10.441636,"median":-3.386242,"eighty":-0.690627,"marketCap":9691953},{"date":"2025-04-25","current":-0.305981,"twenty":-10.150385,"median":-2.970388,"eighty":-0.680801,"marketCap":24472182},{"date":"2025-04-30","current":-0.117902,"twenty":-10.063067,"median":-2.859389,"eighty":-0.677139,"marketCap":9429739}],"updateTime":1746103012110}}}